Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
M.D Anil Gupta, M.D Yaneicy Gonzalez-Rojas, M.D Erick Juarez, M.D Manuel Crespo Casal, M.D Jaynier Moya, M.D Diego R Falci, Ph.D Elias Sarkis, M.D Joel Solis, M.D Hanzhe Zheng, Ph.D Nicola Scott, M.Sc Andrea L Cathcart, Ph.D Christy M Hebner, Ph.D Jennifer Sager, Ph.D Erik Mogalian, Ph.D Craig Tipple, Ph.D Amanda Peppercorn, M.D Elizabeth Alexander, M.D Phillip S Pang, Ph.D Almena Free, M.D Cynthia Brinson, M.D Melissa Aldinger, Pharm.D Adrienne E Shapiro
New England Journal of Medicine, doi:10.1056/nejmoa2107934
BACKGROUND Coronavirus disease 2019 (Covid-19) disproportionately results in hospitalization or death in older patients and those with underlying conditions. Sotrovimab is a pan-sarbecovirus monoclonal antibody that was designed to prevent progression of Covid-19 in high-risk patients early in the course of disease.
METHODS
CONCLUSIONS Among high-risk patients with mild-to-moderate Covid-19, sotrovimab reduced the risk of disease progression. No safety signals were identified. (Funded by Vir Biotechnology and GlaxoSmithKline; COMET-ICE ClinicalTrials.gov number, NCT04545060.
against the non-receptor-binding motif, which does not directly block the ACE2 receptor interaction, can be clinically therapeutic, and thus the results suggest a role for other receptors. 27 Second, because sotrovimab has potent effector function, the efficacy and absence of safety signals suggest that effector function is neither detrimental nor associated with antibody-dependent enhancement. 26 In fact, preclinical models of Covid-19 suggest that the potent effector function of this agent may be beneficial. 13, 14 The results of this interim analysis of COMET-ICE indicate that sotrovimab can be a therapeutic agent for outpatients with Covid-19. Notably, a 500-mg dose may also permit intramuscular administration, which may increase the convenience of and access to therapeutic antibody agents for patients with Covid-19. Studies are currently under way to evaluate this route of administration. Given its in vitro activity against variants of interest and concern, 14 as well as its ability to neutralize other sarbecoviruses, we speculate that sotrovimab has the potential to remain therapeutically active even as SARS-CoV-2 continues to evolve. Supported by Vir Biotechnology and GlaxoSmithKline. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org. A data sharing statement provided by the authors is available with the full text of this article at NEJM.org.
References
Angulo, Finelli, Swerdlow, Estimation of US SARS-CoV-2 infections, symptomatic infections, hospitalizations, and deaths using seroprevalence surveys, JAMA Netw Open
Arvin, Fink, Schmid, A perspective on potential antibody-dependent enhancement of SARS-CoV-2, Nature
Cariou, Hadjadj, Wargny, Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study, Diabetologia
Cathcart, Havenar-Daughton, Lempp, The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2,
doi:10.1101/2021.03.09.434607v6Chen, Nirula, Heller, SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19, N Engl J Med
Chen, Zhang, Case, Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serumderived polyclonal antibodies, Nat Med
Focosi, Maggi, Neutralising antibody escape of SARS-CoV-2 spike protein: risk assessment for antibody-based Covid-19 therapeutics and vaccines, Rev Med Virol
Gaudinski, Coates, Houser, Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: a phase 1 open-label clinical trial in healthy adults, PLoS Med
Huang, Wang, Li, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet
Hwang, Shih, Cani, Group sequential designs using a family of type I error probability spending functions, Stat Med
Ko, Pegu, Rudicell, Enhanced neonatal Fc receptor function improves protection against primate SHIV infection, Nature
Lempp, Soriaga, Montiel-Ruiz, Membrane lectins enhance SARS-CoV-2 infection and influence the neutralizing activity of different classes of antibodies,
doi:10.1101/2021.04.03.438258v1Levey, Bosch, Lewis, Greene, Rogers et al., A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation, Ann Intern Med
Liang, Liang, Ou, Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19, JAMA Intern Med
Petrilli, Jones, Yang, Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study, BMJ
Pinto, Park, Beltramello, Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody, Nature
Reese, Iuliano, Patel, Estimated incidence of coronavirus disease 2019 (COVID-19) illness and hospitalization -United States, February-September 2020, Clin Infect Dis
Starr, Greaney, Dingens, Bloom, Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016, Cell Rep Med
Tada, Dcosta, Zhou, Vaill, Kazmierski et al., Decreased neutralization of SARS-CoV-2 global variants by therapeutic anti-spike protein monoclonal antibodies,
doi:10.1101/2021.02.18.431897v1Wang, Nair, Liu, Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7, Nature
Weinreich, Sivapalasingam, Norton, REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19, N Engl J Med
Zalevsky, Chamberlain, Horton, Enhanced antibody half-life improves in vivo activity, Nat Biotechnol
{ 'indexed': {'date-parts': [[2024, 5, 13]], 'date-time': '2024-05-13T15:11:28Z', 'timestamp': 1715613088511},
'reference-count': 20,
'publisher': 'Massachusetts Medical Society',
'issue': '21',
'license': [ { 'start': { 'date-parts': [[2021, 11, 18]],
'date-time': '2021-11-18T00:00:00Z',
'timestamp': 1637193600000},
'content-version': 'vor',
'delay-in-days': 0,
'URL': 'http://www.nejmgroup.org/legal/terms-of-use.htm'}],
'funder': [ { 'DOI': '10.13039/100004330',
'name': 'Vir Biotechnology, Inc., in collaboration with GlaxoSmithKline',
'doi-asserted-by': 'publisher'}],
'content-domain': {'domain': [], 'crossmark-restriction': False},
'published-print': {'date-parts': [[2021, 11, 18]]},
'DOI': '10.1056/nejmoa2107934',
'type': 'journal-article',
'created': { 'date-parts': [[2021, 10, 27]],
'date-time': '2021-10-27T21:00:49Z',
'timestamp': 1635368449000},
'page': '1941-1950',
'source': 'Crossref',
'is-referenced-by-count': 805,
'title': 'Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab',
'prefix': '10.1056',
'volume': '385',
'author': [ { 'given': 'Anil',
'family': 'Gupta',
'sequence': 'first',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Yaneicy',
'family': 'Gonzalez-Rojas',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Erick',
'family': 'Juarez',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Manuel',
'family': 'Crespo Casal',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Jaynier',
'family': 'Moya',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Diego R.',
'family': 'Falci',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Elias',
'family': 'Sarkis',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Joel',
'family': 'Solis',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Hanzhe',
'family': 'Zheng',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Nicola',
'family': 'Scott',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Andrea L.',
'family': 'Cathcart',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Christy M.',
'family': 'Hebner',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Jennifer',
'family': 'Sager',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Erik',
'family': 'Mogalian',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Craig',
'family': 'Tipple',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Amanda',
'family': 'Peppercorn',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Elizabeth',
'family': 'Alexander',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Phillip S.',
'family': 'Pang',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Almena',
'family': 'Free',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Cynthia',
'family': 'Brinson',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'given': 'Melissa',
'family': 'Aldinger',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]},
{ 'ORCID': 'http://orcid.org/0000-0002-3106-1258',
'authenticated-orcid': False,
'given': 'Adrienne E.',
'family': 'Shapiro',
'sequence': 'additional',
'affiliation': [ { 'name': 'From the Albion Finch Medical Centre, William Osler Health '
'Centre, Toronto (A.G.); Optimus U (Y.G.-R.) and Florida '
'International Medical Research (E.J.), Miami, Pines Care '
'Research Center, Pembroke Pines (J.M.), and Sarkis Clinical '
'Trials, Gainesville (E.S.) — all in Florida; Álvaro Cunqueiro '
'Hospital, IIS Galicia Sur, Vigo, Spain (M.C.C.); Hospital de '
'Clínicas de Porto Alegre, Porto Alegre, Brazil (D.R.F.); Centex '
'Studies, McAllen (J. Solis), and Central Texas Clinical '
'Research, Austin (C.B.) — both in...'}]}],
'member': '150',
'reference': [ {'key': 'r2', 'doi-asserted-by': 'publisher', 'DOI': '10.1001/jamanetworkopen.2020.33706'},
{'key': 'r3', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/cid/ciaa1780'},
{'key': 'r4', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmj.m1966'},
{'key': 'r5', 'doi-asserted-by': 'publisher', 'DOI': '10.1001/jamainternmed.2020.2033'},
{'key': 'r6', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s00125-020-05180-x'},
{'key': 'r7', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/S0140-6736(20)30183-5'},
{'key': 'r8', 'doi-asserted-by': 'publisher', 'DOI': '10.15585/mmwr.mm6912e2'},
{'key': 'r9', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2029849'},
{'key': 'r10', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2035002'},
{'key': 'r11', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41586-021-03398-2'},
{'key': 'r12', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41591-021-01294-w'},
{'key': 'r13', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41586-020-2349-y'},
{'key': 'r16', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/rmv.2231'},
{'key': 'r18', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.xcrm.2021.100255'},
{'key': 'r20', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/nature13612'},
{'key': 'r21', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/nbt.1601'},
{'key': 'r22', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pmed.1002493'},
{ 'key': 'r23',
'doi-asserted-by': 'publisher',
'DOI': '10.7326/0003-4819-130-6-199903160-00002'},
{'key': 'r25', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/sim.4780091207'},
{'key': 'r26', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41586-020-2538-8'}],
'container-title': 'New England Journal of Medicine',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'http://www.nejm.org/doi/pdf/10.1056/NEJMoa2107934',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2021, 11, 17]],
'date-time': '2021-11-17T23:04:52Z',
'timestamp': 1637190292000},
'score': 1,
'resource': {'primary': {'URL': 'http://www.nejm.org/doi/10.1056/NEJMoa2107934'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2021, 11, 18]]},
'references-count': 20,
'journal-issue': {'issue': '21', 'published-print': {'date-parts': [[2021, 11, 18]]}},
'alternative-id': ['10.1056/NEJMoa2107934'],
'URL': 'http://dx.doi.org/10.1056/NEJMoa2107934',
'relation': { 'has-preprint': [ { 'id-type': 'doi',
'id': '10.1101/2021.05.27.21257096',
'asserted-by': 'object'}]},
'ISSN': ['0028-4793', '1533-4406'],
'subject': [],
'container-title-short': 'N Engl J Med',
'published': {'date-parts': [[2021, 11, 18]]}}
